JNCE
VOYA Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,274
| Closed | -$33.8K | – | 3065 |
|
|
2023
Q1 | $33.8K | Sell |
18,274
-137,386
| -88% | -$254K | ﹤0.01% | 2839 |
|
|
2022
Q4 | $173K | Buy |
155,660
+95,730
| +160% | +$106K | ﹤0.01% | 2623 |
|
|
2022
Q3 | $140K | Buy |
59,930
+7,552
| +14% | +$17.7K | ﹤0.01% | 2703 |
|
|
2022
Q2 | $159K | Buy |
52,378
+20,734
| +66% | +$62.9K | ﹤0.01% | 2481 |
|
|
2022
Q1 | $215K | Sell |
31,644
-251
| -0.8% | -$1.71K | ﹤0.01% | 2331 |
|
|
2021
Q4 | $266K | Sell |
31,895
-105
| -0.3% | -$876 | ﹤0.01% | 2368 |
|
|
2021
Q3 | $238K | Buy |
32,000
+307
| +1% | +$2.28K | ﹤0.01% | 2478 |
|
|
2021
Q2 | $216K | Buy |
31,693
+12,171
| +62% | +$83K | ﹤0.01% | 2560 |
|
|
2021
Q1 | $200K | Buy |
+19,522
| New | +$200K | ﹤0.01% | 2548 |
|